Yoav Sebba

For the past 20+ years, I have been on a mission to uncover future category leaders & apply my expertise to help them grow. I am a Managing Director at XT Venture Capital, which is the venture capital arm of the global shipping & industrial group XT Holdings. Prior to XT Venture Capital, I served as a partner in Yozma Venture Capital, in which XT Holdings was a founding partner. I am currently active on the board of directors of ZIM [NYSE: ZIM], Sofwave [TASE: SOFW], Beyeonics, Cymbio, Epitomee [TASE: EPIT], NeuReality, BlueThrone, Healthy.io and Phytech. I had the pleasure to serve on the board of directors of Cognitens (acquired by Hexagon; STO: HEXAB), Kailight Photonics (acquired by Optium; Nasdaq: OPTM), Impactia Technologies (acquired by eWave), BeamUps Technologies, Applied Spectral Imaging, Paragon Communications, Pegasus Technologies, Cognifit, Tevet (acquired by NanoMetrics; Nasdaq: NANO), CommonSense (M&A via a secondary transaction), KiloLambda (M&A via a secondary transaction), HyWire, NanoPass, IntraTech, PainReform [Nasdaq: PRFX] and NextNine (acquired by Honeywell). I hold a B.Sc. in Management and Industrial Engineering, cum laude, from the Technion Institute of Technology, and an MBA from Haifa University. Who and what am I looking for? Israeli entrepreneurs with game-changing technology who are seeking funding (seed, series A/B) for their startup. We can support you with capital, a broad network of connections, operational knowhow, and 24/7 advice - all based on decades of experience in taking companies from any stage to category leadership. I’m available at yoav.s@xtholdings.com